GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » Net Margin %

Renata (DHA:RENATA) Net Margin % : 5.49% (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Renata Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Renata's Net Income for the three months ended in Mar. 2025 was BDT588 Mil. Renata's Revenue for the three months ended in Mar. 2025 was BDT10,708 Mil. Therefore, Renata's net margin for the quarter that ended in Mar. 2025 was 5.49%.

The historical rank and industry rank for Renata's Net Margin % or its related term are showing as below:

DHA:RENATA' s Net Margin % Range Over the Past 10 Years
Min: 6.8   Med: 16.18   Max: 16.89
Current: 6.8


DHA:RENATA's Net Margin % is ranked better than
56.33% of 971 companies
in the Drug Manufacturers industry
Industry Median: 4.87 vs DHA:RENATA: 6.80

Renata Net Margin % Historical Data

The historical data trend for Renata's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renata Net Margin % Chart

Renata Annual Data
Trend Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.26 16.89 16.45 7.09 9.59

Renata Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.93 10.02 5.85 6.05 5.49

Competitive Comparison of Renata's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Renata's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renata's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renata's Net Margin % distribution charts can be found below:

* The bar in red indicates where Renata's Net Margin % falls into.


;
;

Renata Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Renata's Net Margin for the fiscal year that ended in Jun. 2024 is calculated as

Net Margin=Net Income (A: Jun. 2024 )/Revenue (A: Jun. 2024 )
=3615.814/37708.821
=9.59 %

Renata's Net Margin for the quarter that ended in Mar. 2025 is calculated as

Net Margin=Net Income (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=587.623/10708.449
=5.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renata  (DHA:RENATA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Renata Net Margin % Related Terms

Thank you for viewing the detailed overview of Renata's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Renata Business Description

Traded in Other Exchanges
N/A
Address
Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Renata PLC is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata Headlines

No Headlines